Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study
Abstract Background Malaria, caused by Plasmodium falciparum and Plasmodium vivax, is commonly reported in Ethiopia. The World Health Organization (WHO) recommends treating P. vivax malaria with a schizonticidal drug and a 14-day course of primaquine (0.25–0.5 mg/kg body weight daily) to prevent rel...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-12-01
|
| Serier: | Malaria Journal |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12936-025-05709-8 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
